INTUITIVE SURGICAL INC (ISRG) Fundamental Analysis & Valuation

NASDAQ:ISRG • US46120E6023

Current stock price

477.73 USD
-5.03 (-1.04%)
At close:
477.05 USD
-0.68 (-0.14%)
After Hours:

This ISRG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. ISRG Profitability Analysis

1.1 Basic Checks

  • ISRG had positive earnings in the past year.
  • ISRG had a positive operating cash flow in the past year.
  • Each year in the past 5 years ISRG has been profitable.
  • In the past 5 years ISRG always reported a positive cash flow from operatings.
ISRG Yearly Net Income VS EBIT VS OCF VS FCFISRG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • ISRG's Return On Assets of 13.96% is amongst the best of the industry. ISRG outperforms 94.57% of its industry peers.
  • Looking at the Return On Equity, with a value of 16.02%, ISRG belongs to the top of the industry, outperforming 90.22% of the companies in the same industry.
  • The Return On Invested Capital of ISRG (13.95%) is better than 94.57% of its industry peers.
  • ISRG had an Average Return On Invested Capital over the past 3 years of 12.43%. This is above the industry average of 9.18%.
  • The 3 year average ROIC (12.43%) for ISRG is below the current ROIC(13.95%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.96%
ROE 16.02%
ROIC 13.95%
ROA(3y)12.67%
ROA(5y)12.15%
ROE(3y)14.56%
ROE(5y)13.99%
ROIC(3y)12.43%
ROIC(5y)12.44%
ISRG Yearly ROA, ROE, ROICISRG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • With an excellent Profit Margin value of 28.38%, ISRG belongs to the best of the industry, outperforming 97.83% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ISRG has grown nicely.
  • ISRG has a better Operating Margin (29.35%) than 96.74% of its industry peers.
  • In the last couple of years the Operating Margin of ISRG has grown nicely.
  • The Gross Margin of ISRG (66.00%) is better than 71.20% of its industry peers.
  • In the last couple of years the Gross Margin of ISRG has remained more or less at the same level.
Industry RankSector Rank
OM 29.35%
PM (TTM) 28.38%
GM 66%
OM growth 3Y4.58%
OM growth 5Y3.73%
PM growth 3Y10.12%
PM growth 5Y3.12%
GM growth 3Y-0.72%
GM growth 5Y0.11%
ISRG Yearly Profit, Operating, Gross MarginsISRG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. ISRG Health Analysis

2.1 Basic Checks

  • ISRG has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for ISRG has been reduced compared to 1 year ago.
  • The number of shares outstanding for ISRG has been increased compared to 5 years ago.
  • ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ISRG Yearly Shares OutstandingISRG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
ISRG Yearly Total Debt VS Total AssetsISRG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • ISRG has an Altman-Z score of 40.54. This indicates that ISRG is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 40.54, ISRG belongs to the top of the industry, outperforming 98.37% of the companies in the same industry.
  • There is no outstanding debt for ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 40.54
ROIC/WACC1.38
WACC10.1%
ISRG Yearly LT Debt VS Equity VS FCFISRG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • A Current Ratio of 4.87 indicates that ISRG has no problem at all paying its short term obligations.
  • ISRG's Current ratio of 4.87 is fine compared to the rest of the industry. ISRG outperforms 75.54% of its industry peers.
  • A Quick Ratio of 3.96 indicates that ISRG has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 3.96, ISRG is in the better half of the industry, outperforming 72.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.87
Quick Ratio 3.96
ISRG Yearly Current Assets VS Current LiabilitesISRG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. ISRG Growth Analysis

3.1 Past

  • ISRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.83%, which is quite impressive.
  • The Earnings Per Share has been growing by 21.42% on average over the past years. This is a very strong growth
  • ISRG shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.51%.
  • The Revenue has been growing by 18.22% on average over the past years. This is quite good.
EPS 1Y (TTM)21.83%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%14.48%
Revenue 1Y (TTM)20.51%
Revenue growth 3Y17.39%
Revenue growth 5Y18.22%
Sales Q2Q%18.76%

3.2 Future

  • The Earnings Per Share is expected to grow by 13.58% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 12.90% on average over the next years. This is quite good.
EPS Next Y14.45%
EPS Next 2Y14.34%
EPS Next 3Y14.52%
EPS Next 5Y13.58%
Revenue Next Year15.88%
Revenue Next 2Y14.86%
Revenue Next 3Y14.57%
Revenue Next 5Y12.9%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ISRG Yearly Revenue VS EstimatesISRG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B
ISRG Yearly EPS VS EstimatesISRG Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20

More info and screens

Find the best growth stocksShow best growing peers

4

4. ISRG Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 53.50, which means the current valuation is very expensive for ISRG.
  • Based on the Price/Earnings ratio, ISRG is valued a bit cheaper than the industry average as 66.30% of the companies are valued more expensively.
  • ISRG is valuated expensively when we compare the Price/Earnings ratio to 25.79, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 46.74, which means the current valuation is very expensive for ISRG.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ISRG indicates a somewhat cheap valuation: ISRG is cheaper than 67.39% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of ISRG to the average of the S&P500 Index (23.80), we can say ISRG is valued expensively.
Industry RankSector Rank
PE 53.5
Fwd PE 46.74
ISRG Price Earnings VS Forward Price EarningsISRG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • ISRG's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ISRG is cheaper than 66.30% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, ISRG is valued a bit cheaper than the industry average as 71.20% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 68.12
EV/EBITDA 44.33
ISRG Per share dataISRG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The excellent profitability rating of ISRG may justify a higher PE ratio.
  • ISRG's earnings are expected to grow with 14.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.7
PEG (5Y)2.5
EPS Next 2Y14.34%
EPS Next 3Y14.52%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ISRG Dividend Analysis

5.1 Amount

  • ISRG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ISRG Fundamentals: All Metrics, Ratios and Statistics

INTUITIVE SURGICAL INC

NASDAQ:ISRG (3/18/2026, 8:16:33 PM)

After market: 477.05 -0.68 (-0.14%)

477.73

-5.03 (-1.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22
Earnings (Next)04-20
Inst Owners88.53%
Inst Owner Change1.25%
Ins Owners0.45%
Ins Owner Change9.04%
Market Cap169.66B
Revenue(TTM)10.06B
Net Income(TTM)2.86B
Analysts78.1
Price Target624.51 (30.72%)
Short Float %1.88%
Short Ratio3.29
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.28%
Min EPS beat(2)9.85%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)10.81%
Min EPS beat(4)3.05%
Max EPS beat(4)18.71%
EPS beat(8)8
Avg EPS beat(8)11.52%
EPS beat(12)12
Avg EPS beat(12)8.73%
EPS beat(16)14
Avg EPS beat(16)6.39%
Revenue beat(2)2
Avg Revenue beat(2)2.19%
Min Revenue beat(2)2.17%
Max Revenue beat(2)2.22%
Revenue beat(4)4
Avg Revenue beat(4)1.83%
Min Revenue beat(4)1.09%
Max Revenue beat(4)2.22%
Revenue beat(8)5
Avg Revenue beat(8)1.43%
Revenue beat(12)7
Avg Revenue beat(12)0.96%
Revenue beat(16)9
Avg Revenue beat(16)0.46%
PT rev (1m)-0.16%
PT rev (3m)1.8%
EPS NQ rev (1m)-0.06%
EPS NQ rev (3m)0.27%
EPS NY rev (1m)0%
EPS NY rev (3m)3.07%
Revenue NQ rev (1m)-0.07%
Revenue NQ rev (3m)0.45%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)1.02%
Valuation
Industry RankSector Rank
PE 53.5
Fwd PE 46.74
P/S 16.86
P/FCF 68.12
P/OCF 55.98
P/B 9.52
P/tB 9.73
EV/EBITDA 44.33
EPS(TTM)8.93
EY1.87%
EPS(NY)10.22
Fwd EY2.14%
FCF(TTM)7.01
FCFY1.47%
OCF(TTM)8.53
OCFY1.79%
SpS28.34
BVpS50.19
TBVpS49.1
PEG (NY)3.7
PEG (5Y)2.5
Graham Number100.42
Profitability
Industry RankSector Rank
ROA 13.96%
ROE 16.02%
ROCE 16.01%
ROIC 13.95%
ROICexc 20.73%
ROICexgc 21.4%
OM 29.35%
PM (TTM) 28.38%
GM 66%
FCFM 24.75%
ROA(3y)12.67%
ROA(5y)12.15%
ROE(3y)14.56%
ROE(5y)13.99%
ROIC(3y)12.43%
ROIC(5y)12.44%
ROICexc(3y)18.4%
ROICexc(5y)18.81%
ROICexgc(3y)19.07%
ROICexgc(5y)19.65%
ROCE(3y)14.27%
ROCE(5y)14.28%
ROICexgc growth 3Y2.03%
ROICexgc growth 5Y0.92%
ROICexc growth 3Y2.86%
ROICexc growth 5Y2.05%
OM growth 3Y4.58%
OM growth 5Y3.73%
PM growth 3Y10.12%
PM growth 5Y3.12%
GM growth 3Y-0.72%
GM growth 5Y0.11%
F-Score8
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 79.72%
Cap/Sales 5.36%
Interest Coverage 250
Cash Conversion 83.46%
Profit Quality 87.21%
Current Ratio 4.87
Quick Ratio 3.96
Altman-Z 40.54
F-Score8
WACC10.1%
ROIC/WACC1.38
Cap/Depr(3y)178.7%
Cap/Depr(5y)155.64%
Cap/Sales(3y)11.2%
Cap/Sales(5y)9.67%
Profit Quality(3y)61.68%
Profit Quality(5y)71.87%
High Growth Momentum
Growth
EPS 1Y (TTM)21.83%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%14.48%
EPS Next Y14.45%
EPS Next 2Y14.34%
EPS Next 3Y14.52%
EPS Next 5Y13.58%
Revenue 1Y (TTM)20.51%
Revenue growth 3Y17.39%
Revenue growth 5Y18.22%
Sales Q2Q%18.76%
Revenue Next Year15.88%
Revenue Next 2Y14.86%
Revenue Next 3Y14.57%
Revenue Next 5Y12.9%
EBIT growth 1Y25.34%
EBIT growth 3Y22.76%
EBIT growth 5Y22.63%
EBIT Next Year35.56%
EBIT Next 3Y21.57%
EBIT Next 5Y17.26%
FCF growth 1Y91.03%
FCF growth 3Y37.49%
FCF growth 5Y16.85%
OCF growth 1Y25.49%
OCF growth 3Y26.68%
OCF growth 5Y15.34%

INTUITIVE SURGICAL INC / ISRG Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?

ChartMill assigns a fundamental rating of 7 / 10 to ISRG.


What is the valuation status of INTUITIVE SURGICAL INC (ISRG) stock?

ChartMill assigns a valuation rating of 4 / 10 to INTUITIVE SURGICAL INC (ISRG). This can be considered as Fairly Valued.


How profitable is INTUITIVE SURGICAL INC (ISRG) stock?

INTUITIVE SURGICAL INC (ISRG) has a profitability rating of 9 / 10.


What are the PE and PB ratios of INTUITIVE SURGICAL INC (ISRG) stock?

The Price/Earnings (PE) ratio for INTUITIVE SURGICAL INC (ISRG) is 53.5 and the Price/Book (PB) ratio is 9.52.


Can you provide the financial health for ISRG stock?

The financial health rating of INTUITIVE SURGICAL INC (ISRG) is 9 / 10.